Cargando…

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

Therapeutics discovery and development for Alzheimer’s disease (AD) has been an area of intense research to alleviate memory loss and the underlying pathogenic processes. Recent drug discovery approaches have utilized in silico computational strategies for drug candidate selection which has opened t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyarko, Ben, Podvin, Sonia, Greenberg, Barry, Momper, Jeremiah D., Huang, Yadong, Gerwick, William H., Bang, Anne G., Quinti, Luisa, Griciuc, Ana, Kim, Doo Yeon, Tanzi, Rudolph E., Feldman, Howard H., Hook, Vivian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436590/ https://www.ncbi.nlm.nih.gov/pubmed/37601062 http://dx.doi.org/10.3389/fphar.2023.1190402

Ejemplares similares

Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer’s Disease Brain
por: Podvin, Sonia, et al.
Publicado: (2022)

The role of innate immune genes in Alzheimer's disease
por: Griciuc, Ana, et al.
Publicado: (2021)

3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”
por: Choi, Se Hoon, et al.
Publicado: (2016)

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
por: Boyarko, Ben, et al.
Publicado: (2021)

Cromolyn Reduces Levels of the Alzheimer’s Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis
por: Zhang, Can, et al.
Publicado: (2018)

Human brain gene expression profiles of the cathepsin V and cathepsin L cysteine proteases, with the PC1/3 and PC2 serine proteases, involved in neuropeptide production
por: Podvin, Sonia, et al.
Publicado: (2018)

Bumetanide Exposure Association with Alzheimer’s Disease Risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Bumetanide: Metabolic alkalosis: case report
Publicado: (2021)

Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington’s Disease
por: Podvin, Sonia, et al.
Publicado: (2022)

Distinct Cleavage Properties of Cathepsin B Compared to Cysteine Cathepsins Enable the Design and Validation of a Specific Substrate for Cathepsin B over a Broad pH Range
por: Yoon, Michael C., et al.
Publicado: (2023)

A randomised controlled trial of bumetanide in the treatment of autism in children
por: Lemonnier, E, et al.
Publicado: (2012)

Bumetanide for autism: more eye contact, less amygdala activation
por: Hadjikhani, Nouchine, et al.
Publicado: (2018)

Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat
por: Wilkinson, Cassandra M., et al.
Publicado: (2019)

Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior
por: Goubert, Emmanuelle, et al.
Publicado: (2019)

Albumin human/bumetanide: Osmotic demyelination syndrome: case report
Publicado: (2020)

The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero
por: Skorput, Alexander GJ, et al.
Publicado: (2019)

Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease
por: Ning, Shen, et al.
Publicado: (2022)

Human Neurospheroid Arrays for In Vitro Studies of Alzheimer’s Disease
por: Jorfi, Mehdi, et al.
Publicado: (2018)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
por: Nappi, Jean M.
Publicado: (2013)

Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex
por: Vlaskamp, Chantal, et al.
Publicado: (2017)

Longitudinal Effects of Bumetanide on Neuro-Cognitive Functioning in Drug-Resistant Epilepsy
por: Gharaylou, Zeinab, et al.
Publicado: (2019)

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)

Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy
por: Guzel, Sibel, et al.
Publicado: (2020)

Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord Injury
por: Nasirinezhad, Farinaz, et al.
Publicado: (2021)

A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders
por: Delpire, Eric, et al.
Publicado: (2022)

Distinct Dibasic Cleavage Specificities of Neuropeptide-Producing Cathepsin L and Cathepsin V Cysteine Proteases Compared to PC1/3 and PC2 Serine Proteases
por: Yoon, Michael C., et al.
Publicado: (2022)

Differential Neuropeptidomes of Dense Core Secretory Vesicles (DCSV) Produced at Intravesicular and Extracellular pH Conditions by Proteolytic Processing
por: Jiang, Zhenze, et al.
Publicado: (2021)

Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

Effect of Co-administration of Bumetanide and Phenobarbital on Seizure Attacks in Temporal Lobe Epilepsy
por: Rahmanzadeh, Reza, et al.
Publicado: (2018)

Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol
por: Geertjens, Lisa, et al.
Publicado: (2022)

Bumetanide induces post-traumatic microglia–interneuron contact to promote neurogenesis and recovery
por: Tessier, Marine, et al.
Publicado: (2023)

Correction: Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

The extracellular space and epileptic activity in the adult brain: Explaining the antiepileptic effects of furosemide and bumetanide
por: Hochman, Daryl W
Publicado: (2012)

Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress
por: Hu, Die, et al.
Publicado: (2017)

Bumetanide Therapeutic Effect in Children and Adolescents With Autism Spectrum Disorder: A Review Study
por: Mollajani, Raheleh, et al.
Publicado: (2019)

The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis
por: Ben-Ari, Yehezkel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0g86k328qcunr6ocktkr9enuv